BetaThis is a new service - your feedback will help us to improve it.
Information
Changes to when we publish influenza and RSV data
We are changing how often we publish our influenza and RSV data. From 29 May, we will update metrics for both influenza and RSV every 2 weeks instead of weekly. We will resume weekly updates in October this year.
Entry title:
Antimicrobial resistance in Escherichia coli (E. coli)
Last updated on Friday, 2 May 2025 at 05:07pm
This page provides information on resistance to antimicrobials in Escherichia coli bacteraemia (bacteria found in blood specimens) in England.
Antibiotics are grouped based on the UK-AWaRe classification. These are:
Access Access antibiotics are with a narrow spectrum of activity, fewer side effects, lower costs, and importantly lower resistance potential. These are first or second choice antibiotics recommended for empiric treatment of the most common infections and should be widely available. That is to say, these antibiotics should offer the best therapeutic value while minimizing the potential for resistance.
Watch Watch antibiotics have a higher resistance potential and are broader-spectrum antibiotics. These are first or second choice antibiotics indicated for a limited number of infective syndromes. As these antibiotics are considered to have a higher potential for selection of AMR, their use should be carefully monitored.
Reserve Reserve antibiotics are “last resort” antibiotics, including new antibiotics. These are used for highly selected patients (life-threatening infections due to multi-drug-resistant bacteria) and are closely monitored and prioritized as targets of stewardship programmes to ensure continued effectiveness.
Resistance
Rolling monthly average percent of E. coli bacteraemia resistant to co-amoxiclav, ciprofloxacin, gentamicin, piperacillin with tazobactam, amikacin, carbapenems or third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Resistance data for rolling monthly average percent of E. coli bacteraemia resistant to co-amoxiclav, ciprofloxacin, gentamicin, piperacillin with tazobactam, amikacin, carbapenems or third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
Amikacin (Watch)
Carbapenems (Reserve)
1 Jan 2025
5.31
0.19
1 Dec 2024
5.5
0.19
1 Nov 2024
5
0.16
1 Oct 2024
4.62
0.16
1 Sep 2024
4.48
0.11
1 Aug 2024
4.19
0.13
1 Jul 2024
4.11
0.15
1 Jun 2024
3.53
0.32
1 May 2024
3.46
0.31
1 Apr 2024
3.3
0.31
1 Mar 2024
3.21
0.17
1 Feb 2024
3.13
0.19
1 Jan 2024
3.02
0.26
1 Dec 2023
3.16
0.28
1 Nov 2023
3.49
0.27
1 Oct 2023
3.45
0.22
1 Sep 2023
3.34
0.21
1 Aug 2023
3.37
0.26
1 Jul 2023
3.51
0.25
1 Jun 2023
3.61
0.29
1 May 2023
3.1
0.26
1 Apr 2023
3.03
0.26
1 Mar 2023
2.72
0.27
1 Feb 2023
2.94
0.23
1 Jan 2023
3.04
0.24
1 Dec 2022
3.25
0.21
1 Nov 2022
2.76
0.21
1 Oct 2022
2.5
0.18
1 Sep 2022
2.21
0.14
1 Aug 2022
2.43
0.14
1 Jul 2022
2.19
0.13
1 Jun 2022
2.13
0.1
1 May 2022
2.11
0.1
1 Apr 2022
2.36
0.13
1 Mar 2022
2.32
0.16
1 Feb 2022
2.21
0.2
1 Jan 2022
1.95
0.23
1 Dec 2021
1.89
0.18
1 Nov 2021
1.74
0.17
1 Oct 2021
1.8
0.18
1 Sep 2021
1.72
0.26
1 Aug 2021
1.65
0.21
1 Jul 2021
1.53
0.18
1 Jun 2021
1.68
0.14
1 May 2021
1.77
0.19
1 Apr 2021
1.63
0.15
1 Mar 2021
1.41
0.11
1 Feb 2021
1.39
0.12
1 Jan 2021
1.48
0.12
1 Dec 2020
1.65
0.16
1 Nov 2020
1.33
0.13
1 Oct 2020
1.17
0.14
1 Sep 2020
0.96
0.12
1 Aug 2020
1.1
0.11
1 Jul 2020
1.07
0.18
1 Jun 2020
1.01
0.27
1 May 2020
0.91
0.3
1 Apr 2020
0.94
0.23
1 Mar 2020
0.93
0.15
Month
Ciprofloxacin (Watch)
Co-amoxiclav (Watch)
1 Jan 2025
19.65
43.05
1 Dec 2024
19.89
42.85
1 Nov 2024
19.29
42.78
1 Oct 2024
18.99
42.77
1 Sep 2024
19.38
42.87
1 Aug 2024
19.79
42.52
1 Jul 2024
20.12
42.4
1 Jun 2024
19.71
41.65
1 May 2024
19.71
41.39
1 Apr 2024
19.76
40.91
1 Mar 2024
19.54
41.01
1 Feb 2024
19.43
41.92
1 Jan 2024
19.85
43.06
1 Dec 2023
20.02
43.91
1 Nov 2023
19.77
43.17
1 Oct 2023
19.3
42.28
1 Sep 2023
19.25
41.64
1 Aug 2023
19.56
42.2
1 Jul 2023
19.5
42.17
1 Jun 2023
19.89
42.87
1 May 2023
19.16
42.99
1 Apr 2023
18.84
43.8
1 Mar 2023
17.55
44.41
1 Feb 2023
18.16
44.39
1 Jan 2023
18.32
43.57
1 Dec 2022
18.86
42.94
1 Nov 2022
18.43
42.1
1 Oct 2022
18.26
42.14
1 Sep 2022
18.26
41.57
1 Aug 2022
18.11
41.03
1 Jul 2022
17.95
40.84
1 Jun 2022
17.86
40.91
1 May 2022
17.83
41.44
1 Apr 2022
17.72
41.65
1 Mar 2022
17.14
41.55
1 Feb 2022
17.08
41.93
1 Jan 2022
17.26
42.69
1 Dec 2021
17.54
43.17
1 Nov 2021
17.2
42.6
1 Oct 2021
17.18
41.91
1 Sep 2021
16.74
41.4
1 Aug 2021
16.7
40.85
1 Jul 2021
16.22
39.62
1 Jun 2021
16.61
39.14
1 May 2021
17.14
40.17
1 Apr 2021
17.69
41.48
1 Mar 2021
18.35
42.33
1 Feb 2021
18.68
42.55
1 Jan 2021
18.37
42.49
1 Dec 2020
17.93
42.73
1 Nov 2020
17.87
42.79
1 Oct 2020
17.99
42.9
1 Sep 2020
17.78
42.35
1 Aug 2020
17.35
42.17
1 Jul 2020
17.66
42.58
1 Jun 2020
18.36
43.65
1 May 2020
19.1
44.85
1 Apr 2020
20.22
46.32
1 Mar 2020
20.13
46.08
Month
Gentamicin (Access)
Piperacillin with tazobactam (Watch)
1 Jan 2025
12.29
12.95
1 Dec 2024
12.45
12.72
1 Nov 2024
11.92
11.47
1 Oct 2024
11.62
11.46
1 Sep 2024
12.22
11.47
1 Aug 2024
12.71
12.02
1 Jul 2024
12.95
12.38
1 Jun 2024
12.52
12.72
1 May 2024
12.75
12.44
1 Apr 2024
12.86
12.46
1 Mar 2024
12.52
12.11
1 Feb 2024
12.13
12.68
1 Jan 2024
11.81
12.6
1 Dec 2023
11.83
12.76
1 Nov 2023
11.83
12.76
1 Oct 2023
11.72
12.59
1 Sep 2023
11.77
12.11
1 Aug 2023
11.98
12.21
1 Jul 2023
11.75
12.15
1 Jun 2023
11.8
12.84
1 May 2023
11.34
12.43
1 Apr 2023
11.07
12.51
1 Mar 2023
10.44
11.75
1 Feb 2023
10.53
11.39
1 Jan 2023
10.82
10.76
1 Dec 2022
11.22
10.49
1 Nov 2022
10.46
10.76
1 Oct 2022
10.64
11
1 Sep 2022
10.45
11.26
1 Aug 2022
10.79
10.92
1 Jul 2022
10.52
10.73
1 Jun 2022
10.51
10.54
1 May 2022
10.37
10.67
1 Apr 2022
10.68
10.74
1 Mar 2022
10.35
10.16
1 Feb 2022
10.56
9.81
1 Jan 2022
10.38
10.08
1 Dec 2021
10.42
10.96
1 Nov 2021
9.98
11.08
1 Oct 2021
9.64
10.8
1 Sep 2021
9.37
10.34
1 Aug 2021
9.29
10.01
1 Jul 2021
9.2
9.64
1 Jun 2021
9.46
9.68
1 May 2021
9.74
9.46
1 Apr 2021
9.83
9.59
1 Mar 2021
9.43
9.42
1 Feb 2021
9.43
10.09
1 Jan 2021
9.24
9.78
1 Dec 2020
10.08
9.53
1 Nov 2020
10.48
9.2
1 Oct 2020
10.63
9.24
1 Sep 2020
10.31
9.21
1 Aug 2020
9.94
8.83
1 Jul 2020
10.29
8.5
1 Jun 2020
10.52
8.29
1 May 2020
10.52
8.96
1 Apr 2020
10.83
9.94
1 Mar 2020
10.95
10.09
Month
Third-generation cephalosporins (Watch)
1 Jan 2025
17.31
1 Dec 2024
17.67
1 Nov 2024
17.25
1 Oct 2024
17.06
1 Sep 2024
17.16
1 Aug 2024
16.99
1 Jul 2024
17.34
1 Jun 2024
16.94
1 May 2024
17.08
1 Apr 2024
16.73
1 Mar 2024
16.08
1 Feb 2024
16
1 Jan 2024
15.77
1 Dec 2023
16.3
1 Nov 2023
16.04
1 Oct 2023
15.8
1 Sep 2023
15.85
1 Aug 2023
15.82
1 Jul 2023
15.94
1 Jun 2023
16.05
1 May 2023
16.09
1 Apr 2023
16.05
1 Mar 2023
15.25
1 Feb 2023
15.48
1 Jan 2023
15.26
1 Dec 2022
15.39
1 Nov 2022
14.79
1 Oct 2022
14.75
1 Sep 2022
14.83
1 Aug 2022
14.57
1 Jul 2022
14.51
1 Jun 2022
14.15
1 May 2022
14.02
1 Apr 2022
13.67
1 Mar 2022
13.56
1 Feb 2022
13.22
1 Jan 2022
13.65
1 Dec 2021
13.33
1 Nov 2021
13.46
1 Oct 2021
13.27
1 Sep 2021
13.36
1 Aug 2021
13.54
1 Jul 2021
13.33
1 Jun 2021
13.44
1 May 2021
13.37
1 Apr 2021
13.54
1 Mar 2021
13.98
1 Feb 2021
14.18
1 Jan 2021
13.79
1 Dec 2020
13.72
1 Nov 2020
13.18
1 Oct 2020
13.41
1 Sep 2020
12.83
1 Aug 2020
13.05
1 Jul 2020
13.04
1 Jun 2020
13.48
1 May 2020
14.46
1 Apr 2020
15.23
1 Mar 2020
15.73
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average number of E. coli bacteraemia tested for resistance to amikacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average number of E. coli bacteraemia tested for resistance to amikacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
Number tested
1 Jan 2025
2,089.33
1 Dec 2024
2,170.33
1 Nov 2024
2,247.67
1 Oct 2024
2,345.67
1 Sep 2024
2,387.67
1 Aug 2024
2,364
1 Jul 2024
2,310
1 Jun 2024
2,237.33
1 May 2024
2,203.33
1 Apr 2024
2,092.67
1 Mar 2024
2,074
1 Feb 2024
2,043.67
1 Jan 2024
2,076.67
1 Dec 2023
2,097.33
1 Nov 2023
2,170.67
1 Oct 2023
2,221.67
1 Sep 2023
2,285.67
1 Aug 2023
2,256
1 Jul 2023
2,203
1 Jun 2023
2,079.67
1 May 2023
2,021.33
1 Apr 2023
1,938
1 Mar 2023
1,900.67
1 Feb 2023
1,838
1 Jan 2023
1,886
1 Dec 2022
1,915.33
1 Nov 2022
2,044
1 Oct 2022
2,078
1 Sep 2022
2,107
1 Aug 2022
2,005.33
1 Jul 2022
1,933
1 Jun 2022
1,882
1 May 2022
1,880.67
1 Apr 2022
1,838.33
1 Mar 2022
1,811.67
1 Feb 2022
1,783
1 Jan 2022
1,829.33
1 Dec 2021
1,854.67
1 Nov 2021
1,901.67
1 Oct 2021
1,965
1 Sep 2021
2,049
1 Aug 2021
2,045.67
1 Jul 2021
2,006
1 Jun 2021
1,921.33
1 May 2021
1,900.33
1 Apr 2021
1,782
1 Mar 2021
1,677
1 Feb 2021
1,634
1 Jan 2021
1,663.67
1 Dec 2020
1,719.67
1 Nov 2020
1,757.67
1 Oct 2020
1,847.33
1 Sep 2020
1,874.67
1 Aug 2020
1,820.67
1 Jul 2020
1,715.33
1 Jun 2020
1,577
1 May 2020
1,613
1 Apr 2020
1,703.33
1 Mar 2020
1,940.33
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of E. coli bacteraemia tested for resistance to amikacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average percent of E. coli bacteraemia tested for resistance to amikacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
% tested
1 Jan 2025
63.81
1 Dec 2024
64.37
1 Nov 2024
65.74
1 Oct 2024
66.62
1 Sep 2024
67.68
1 Aug 2024
67.14
1 Jul 2024
67.5
1 Jun 2024
67.32
1 May 2024
67.66
1 Apr 2024
66.71
1 Mar 2024
66.71
1 Feb 2024
66.68
1 Jan 2024
67.62
1 Dec 2023
67.67
1 Nov 2023
68.22
1 Oct 2023
67.26
1 Sep 2023
67.9
1 Aug 2023
67.38
1 Jul 2023
67.43
1 Jun 2023
66.91
1 May 2023
67.19
1 Apr 2023
67.76
1 Mar 2023
68.03
1 Feb 2023
68.51
1 Jan 2023
68.19
1 Dec 2022
68.05
1 Nov 2022
67.48
1 Oct 2022
67.01
1 Sep 2022
66.95
1 Aug 2022
67.3
1 Jul 2022
68.04
1 Jun 2022
68.41
1 May 2022
68.54
1 Apr 2022
69.12
1 Mar 2022
68.89
1 Feb 2022
68.92
1 Jan 2022
68.53
1 Dec 2021
68.9
1 Nov 2021
67.94
1 Oct 2021
67.9
1 Sep 2021
68.35
1 Aug 2021
68.23
1 Jul 2021
67.63
1 Jun 2021
66.82
1 May 2021
66.83
1 Apr 2021
67.14
1 Mar 2021
66.02
1 Feb 2021
66.59
1 Jan 2021
66.63
1 Dec 2020
67.62
1 Nov 2020
67.24
1 Oct 2020
66.8
1 Sep 2020
65.96
1 Aug 2020
65.61
1 Jul 2020
65.38
1 Jun 2020
65.85
1 May 2020
66.79
1 Apr 2020
66.92
1 Mar 2020
67.13
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of E. coli bacteraemia resistant to amikacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Resistance data for rolling monthly average percent of E. coli bacteraemia resistant to amikacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
% resistant
1 Jan 2025
5.31
1 Dec 2024
5.5
1 Nov 2024
5
1 Oct 2024
4.62
1 Sep 2024
4.48
1 Aug 2024
4.19
1 Jul 2024
4.11
1 Jun 2024
3.53
1 May 2024
3.46
1 Apr 2024
3.3
1 Mar 2024
3.21
1 Feb 2024
3.13
1 Jan 2024
3.02
1 Dec 2023
3.16
1 Nov 2023
3.49
1 Oct 2023
3.45
1 Sep 2023
3.34
1 Aug 2023
3.37
1 Jul 2023
3.51
1 Jun 2023
3.61
1 May 2023
3.1
1 Apr 2023
3.03
1 Mar 2023
2.72
1 Feb 2023
2.94
1 Jan 2023
3.04
1 Dec 2022
3.25
1 Nov 2022
2.76
1 Oct 2022
2.5
1 Sep 2022
2.21
1 Aug 2022
2.43
1 Jul 2022
2.19
1 Jun 2022
2.13
1 May 2022
2.11
1 Apr 2022
2.36
1 Mar 2022
2.32
1 Feb 2022
2.21
1 Jan 2022
1.95
1 Dec 2021
1.89
1 Nov 2021
1.74
1 Oct 2021
1.8
1 Sep 2021
1.72
1 Aug 2021
1.65
1 Jul 2021
1.53
1 Jun 2021
1.68
1 May 2021
1.77
1 Apr 2021
1.63
1 Mar 2021
1.41
1 Feb 2021
1.39
1 Jan 2021
1.48
1 Dec 2020
1.65
1 Nov 2020
1.33
1 Oct 2020
1.17
1 Sep 2020
0.96
1 Aug 2020
1.1
1 Jul 2020
1.07
1 Jun 2020
1.01
1 May 2020
0.91
1 Apr 2020
0.94
1 Mar 2020
0.93
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average number of E. coli bacteraemia tested for resistance to carbapenems. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average number of E. coli bacteraemia tested for resistance to carbapenems. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
Number tested
1 Jan 2025
3,132
1 Dec 2024
3,255
1 Nov 2024
3,310.67
1 Oct 2024
3,412
1 Sep 2024
3,410.67
1 Aug 2024
3,402.33
1 Jul 2024
3,310.33
1 Jun 2024
3,210.67
1 May 2024
3,149
1 Apr 2024
3,023.33
1 Mar 2024
2,996
1 Feb 2024
2,951.33
1 Jan 2024
2,964.33
1 Dec 2023
3,001.33
1 Nov 2023
3,089.33
1 Oct 2023
3,207.33
1 Sep 2023
3,264
1 Aug 2023
3,242.33
1 Jul 2023
3,164
1 Jun 2023
3,014.67
1 May 2023
2,921.67
1 Apr 2023
2,782
1 Mar 2023
2,716
1 Feb 2023
2,610.67
1 Jan 2023
2,691.33
1 Dec 2022
2,740
1 Nov 2022
2,947
1 Oct 2022
3,018.33
1 Sep 2022
3,064
1 Aug 2022
2,905.33
1 Jul 2022
2,770
1 Jun 2022
2,689
1 May 2022
2,681.33
1 Apr 2022
2,600.33
1 Mar 2022
2,566.67
1 Feb 2022
2,526
1 Jan 2022
2,606.67
1 Dec 2021
2,624.67
1 Nov 2021
2,720.67
1 Oct 2021
2,809.33
1 Sep 2021
2,910.67
1 Aug 2021
2,917
1 Jul 2021
2,896.33
1 Jun 2021
2,813
1 May 2021
2,782.33
1 Apr 2021
2,592.33
1 Mar 2021
2,487.33
1 Feb 2021
2,405
1 Jan 2021
2,452
1 Dec 2020
2,487.33
1 Nov 2020
2,558.67
1 Oct 2020
2,704.33
1 Sep 2020
2,777.33
1 Aug 2020
2,709.33
1 Jul 2020
2,557
1 Jun 2020
2,336.33
1 May 2020
2,348.67
1 Apr 2020
2,478
1 Mar 2020
2,807
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of E. coli bacteraemia tested for resistance to carbapenems. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average percent of E. coli bacteraemia tested for resistance to carbapenems. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
% tested
1 Jan 2025
95.66
1 Dec 2024
96.56
1 Nov 2024
96.84
1 Oct 2024
96.93
1 Sep 2024
96.68
1 Aug 2024
96.62
1 Jul 2024
96.73
1 Jun 2024
96.6
1 May 2024
96.71
1 Apr 2024
96.4
1 Mar 2024
96.37
1 Feb 2024
96.31
1 Jan 2024
96.55
1 Dec 2023
96.84
1 Nov 2023
97.11
1 Oct 2023
97.12
1 Sep 2023
97
1 Aug 2023
96.83
1 Jul 2023
96.85
1 Jun 2023
97.01
1 May 2023
97.11
1 Apr 2023
97.27
1 Mar 2023
97.24
1 Feb 2023
97.28
1 Jan 2023
97.29
1 Dec 2022
97.37
1 Nov 2022
97.29
1 Oct 2022
97.32
1 Sep 2022
97.36
1 Aug 2022
97.52
1 Jul 2022
97.5
1 Jun 2022
97.75
1 May 2022
97.74
1 Apr 2022
97.78
1 Mar 2022
97.6
1 Feb 2022
97.64
1 Jan 2022
97.64
1 Dec 2021
97.51
1 Nov 2021
97.21
1 Oct 2021
97.06
1 Sep 2021
97.06
1 Aug 2021
97.33
1 Jul 2021
97.64
1 Jun 2021
97.84
1 May 2021
97.85
1 Apr 2021
97.66
1 Mar 2021
97.91
1 Feb 2021
98
1 Jan 2021
98.24
1 Dec 2020
97.84
1 Nov 2020
97.9
1 Oct 2020
97.79
1 Sep 2020
97.75
1 Aug 2020
97.66
1 Jul 2020
97.48
1 Jun 2020
97.54
1 May 2020
97.23
1 Apr 2020
97.37
1 Mar 2020
97.13
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of E. coli bacteraemia resistant to carbapenems. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Resistance data for rolling monthly average percent of E. coli bacteraemia resistant to carbapenems. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
% resistant
1 Jan 2025
0.19
1 Dec 2024
0.19
1 Nov 2024
0.16
1 Oct 2024
0.16
1 Sep 2024
0.11
1 Aug 2024
0.13
1 Jul 2024
0.15
1 Jun 2024
0.32
1 May 2024
0.31
1 Apr 2024
0.31
1 Mar 2024
0.17
1 Feb 2024
0.19
1 Jan 2024
0.26
1 Dec 2023
0.28
1 Nov 2023
0.27
1 Oct 2023
0.22
1 Sep 2023
0.21
1 Aug 2023
0.26
1 Jul 2023
0.25
1 Jun 2023
0.29
1 May 2023
0.26
1 Apr 2023
0.26
1 Mar 2023
0.27
1 Feb 2023
0.23
1 Jan 2023
0.24
1 Dec 2022
0.21
1 Nov 2022
0.21
1 Oct 2022
0.18
1 Sep 2022
0.14
1 Aug 2022
0.14
1 Jul 2022
0.13
1 Jun 2022
0.1
1 May 2022
0.1
1 Apr 2022
0.13
1 Mar 2022
0.16
1 Feb 2022
0.2
1 Jan 2022
0.23
1 Dec 2021
0.18
1 Nov 2021
0.17
1 Oct 2021
0.18
1 Sep 2021
0.26
1 Aug 2021
0.21
1 Jul 2021
0.18
1 Jun 2021
0.14
1 May 2021
0.19
1 Apr 2021
0.15
1 Mar 2021
0.11
1 Feb 2021
0.12
1 Jan 2021
0.12
1 Dec 2020
0.16
1 Nov 2020
0.13
1 Oct 2020
0.14
1 Sep 2020
0.12
1 Aug 2020
0.11
1 Jul 2020
0.18
1 Jun 2020
0.27
1 May 2020
0.3
1 Apr 2020
0.23
1 Mar 2020
0.15
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average number of E. coli bacteraemia tested for resistance to ciprofloxacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average number of E. coli bacteraemia tested for resistance to ciprofloxacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
Number tested
1 Jan 2025
2,937
1 Dec 2024
3,040
1 Nov 2024
3,088
1 Oct 2024
3,187.33
1 Sep 2024
3,193
1 Aug 2024
3,190
1 Jul 2024
3,111.33
1 Jun 2024
3,036.33
1 May 2024
2,985.33
1 Apr 2024
2,866.67
1 Mar 2024
2,833.67
1 Feb 2024
2,794.67
1 Jan 2024
2,806
1 Dec 2023
2,837.67
1 Nov 2023
2,931.33
1 Oct 2023
3,041
1 Sep 2023
3,110.67
1 Aug 2023
3,086.67
1 Jul 2023
3,026
1 Jun 2023
2,872.67
1 May 2023
2,777.67
1 Apr 2023
2,641
1 Mar 2023
2,581
1 Feb 2023
2,495
1 Jan 2023
2,578.33
1 Dec 2022
2,637.67
1 Nov 2022
2,844.33
1 Oct 2022
2,920
1 Sep 2022
2,973.67
1 Aug 2022
2,818.67
1 Jul 2022
2,698.33
1 Jun 2022
2,621.67
1 May 2022
2,619.33
1 Apr 2022
2,537.67
1 Mar 2022
2,508.33
1 Feb 2022
2,461.67
1 Jan 2022
2,534
1 Dec 2021
2,548.33
1 Nov 2021
2,647
1 Oct 2021
2,733.67
1 Sep 2021
2,833.33
1 Aug 2021
2,840.33
1 Jul 2021
2,822
1 Jun 2021
2,742
1 May 2021
2,713
1 Apr 2021
2,530
1 Mar 2021
2,422.67
1 Feb 2021
2,339.67
1 Jan 2021
2,390.33
1 Dec 2020
2,432
1 Nov 2020
2,503
1 Oct 2020
2,642.67
1 Sep 2020
2,698.33
1 Aug 2020
2,625
1 Jul 2020
2,472.67
1 Jun 2020
2,270
1 May 2020
2,284
1 Apr 2020
2,398.67
1 Mar 2020
2,709
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of E. coli bacteraemia tested for resistance to ciprofloxacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average percent of E. coli bacteraemia tested for resistance to ciprofloxacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
% tested
1 Jan 2025
89.71
1 Dec 2024
90.18
1 Nov 2024
90.35
1 Oct 2024
90.54
1 Sep 2024
90.53
1 Aug 2024
90.6
1 Jul 2024
90.91
1 Jun 2024
91.36
1 May 2024
91.68
1 Apr 2024
91.39
1 Mar 2024
91.12
1 Feb 2024
91.19
1 Jan 2024
91.4
1 Dec 2023
91.55
1 Nov 2023
92.14
1 Oct 2023
92.1
1 Sep 2023
92.42
1 Aug 2023
92.17
1 Jul 2023
92.62
1 Jun 2023
92.44
1 May 2023
92.32
1 Apr 2023
92.34
1 Mar 2023
92.41
1 Feb 2023
92.99
1 Jan 2023
93.2
1 Dec 2022
93.71
1 Nov 2022
93.89
1 Oct 2022
94.16
1 Sep 2022
94.47
1 Aug 2022
94.6
1 Jul 2022
94.97
1 Jun 2022
95.27
1 May 2022
95.48
1 Apr 2022
95.41
1 Mar 2022
95.4
1 Feb 2022
95.13
1 Jan 2022
94.94
1 Dec 2021
94.69
1 Nov 2021
94.6
1 Oct 2021
94.44
1 Sep 2021
94.5
1 Aug 2021
94.76
1 Jul 2021
95.14
1 Jun 2021
95.37
1 May 2021
95.43
1 Apr 2021
95.33
1 Mar 2021
95.35
1 Feb 2021
95.31
1 Jan 2021
95.75
1 Dec 2020
95.67
1 Nov 2020
95.79
1 Oct 2020
95.55
1 Sep 2020
94.97
1 Aug 2020
94.63
1 Jul 2020
94.24
1 Jun 2020
94.78
1 May 2020
94.58
1 Apr 2020
94.22
1 Mar 2020
93.74
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of E. coli bacteraemia resistant to ciprofloxacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Resistance data for rolling monthly average percent of E. coli bacteraemia resistant to ciprofloxacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
% resistant
1 Jan 2025
19.65
1 Dec 2024
19.89
1 Nov 2024
19.29
1 Oct 2024
18.99
1 Sep 2024
19.38
1 Aug 2024
19.79
1 Jul 2024
20.12
1 Jun 2024
19.71
1 May 2024
19.71
1 Apr 2024
19.76
1 Mar 2024
19.54
1 Feb 2024
19.43
1 Jan 2024
19.85
1 Dec 2023
20.02
1 Nov 2023
19.77
1 Oct 2023
19.3
1 Sep 2023
19.25
1 Aug 2023
19.56
1 Jul 2023
19.5
1 Jun 2023
19.89
1 May 2023
19.16
1 Apr 2023
18.84
1 Mar 2023
17.55
1 Feb 2023
18.16
1 Jan 2023
18.32
1 Dec 2022
18.86
1 Nov 2022
18.43
1 Oct 2022
18.26
1 Sep 2022
18.26
1 Aug 2022
18.11
1 Jul 2022
17.95
1 Jun 2022
17.86
1 May 2022
17.83
1 Apr 2022
17.72
1 Mar 2022
17.14
1 Feb 2022
17.08
1 Jan 2022
17.26
1 Dec 2021
17.54
1 Nov 2021
17.2
1 Oct 2021
17.18
1 Sep 2021
16.74
1 Aug 2021
16.7
1 Jul 2021
16.22
1 Jun 2021
16.61
1 May 2021
17.14
1 Apr 2021
17.69
1 Mar 2021
18.35
1 Feb 2021
18.68
1 Jan 2021
18.37
1 Dec 2020
17.93
1 Nov 2020
17.87
1 Oct 2020
17.99
1 Sep 2020
17.78
1 Aug 2020
17.35
1 Jul 2020
17.66
1 Jun 2020
18.36
1 May 2020
19.1
1 Apr 2020
20.22
1 Mar 2020
20.13
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average number of E. coli bacteraemia tested for resistance to co-amoxiclav. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average number of E. coli bacteraemia tested for resistance to co-amoxiclav. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
Number tested
1 Jan 2025
2,865.67
1 Dec 2024
2,974.67
1 Nov 2024
3,031
1 Oct 2024
3,122
1 Sep 2024
3,129.67
1 Aug 2024
3,117.67
1 Jul 2024
3,039.33
1 Jun 2024
2,950.67
1 May 2024
2,902.67
1 Apr 2024
2,784
1 Mar 2024
2,763.33
1 Feb 2024
2,712.33
1 Jan 2024
2,722.33
1 Dec 2023
2,744.33
1 Nov 2023
2,829
1 Oct 2023
2,955.67
1 Sep 2023
3,024.33
1 Aug 2023
3,009.33
1 Jul 2023
2,941
1 Jun 2023
2,808.33
1 May 2023
2,730.33
1 Apr 2023
2,603.33
1 Mar 2023
2,538.67
1 Feb 2023
2,443
1 Jan 2023
2,514.67
1 Dec 2022
2,555
1 Nov 2022
2,754.67
1 Oct 2022
2,823.67
1 Sep 2022
2,886
1 Aug 2022
2,746.67
1 Jul 2022
2,642.33
1 Jun 2022
2,568.33
1 May 2022
2,571.67
1 Apr 2022
2,490
1 Mar 2022
2,457
1 Feb 2022
2,407.33
1 Jan 2022
2,486
1 Dec 2021
2,516.33
1 Nov 2021
2,614.33
1 Oct 2021
2,694
1 Sep 2021
2,783.67
1 Aug 2021
2,784
1 Jul 2021
2,763.67
1 Jun 2021
2,686
1 May 2021
2,662.67
1 Apr 2021
2,489.33
1 Mar 2021
2,389.33
1 Feb 2021
2,312
1 Jan 2021
2,363.67
1 Dec 2020
2,401.33
1 Nov 2020
2,478.67
1 Oct 2020
2,621
1 Sep 2020
2,702
1 Aug 2020
2,628
1 Jul 2020
2,480
1 Jun 2020
2,259
1 May 2020
2,276.67
1 Apr 2020
2,377.67
1 Mar 2020
2,684.67
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of E. coli bacteraemia tested for resistance to co-amoxiclav. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average percent of E. coli bacteraemia tested for resistance to co-amoxiclav. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
% tested
1 Jan 2025
87.51
1 Dec 2024
88.22
1 Nov 2024
88.68
1 Oct 2024
88.69
1 Sep 2024
88.72
1 Aug 2024
88.53
1 Jul 2024
88.81
1 Jun 2024
88.78
1 May 2024
89.13
1 Apr 2024
88.78
1 Mar 2024
88.87
1 Feb 2024
88.51
1 Jan 2024
88.66
1 Dec 2023
88.54
1 Nov 2023
88.93
1 Oct 2023
89.49
1 Sep 2023
89.87
1 Aug 2023
89.87
1 Jul 2023
90.02
1 Jun 2023
90.38
1 May 2023
90.76
1 Apr 2023
91.01
1 Mar 2023
90.87
1 Feb 2023
91.05
1 Jan 2023
90.89
1 Dec 2022
90.8
1 Nov 2022
90.92
1 Oct 2022
91.04
1 Sep 2022
91.71
1 Aug 2022
92.18
1 Jul 2022
93
1 Jun 2022
93.35
1 May 2022
93.73
1 Apr 2022
93.64
1 Mar 2022
93.46
1 Feb 2022
93.04
1 Jan 2022
93.14
1 Dec 2021
93.5
1 Nov 2021
93.42
1 Oct 2021
93.09
1 Sep 2021
92.83
1 Aug 2021
92.89
1 Jul 2021
93.16
1 Jun 2021
93.43
1 May 2021
93.63
1 Apr 2021
93.78
1 Mar 2021
94.06
1 Feb 2021
94.21
1 Jan 2021
94.67
1 Dec 2020
94.45
1 Nov 2020
94.83
1 Oct 2020
94.79
1 Sep 2020
95.11
1 Aug 2020
94.74
1 Jul 2020
94.55
1 Jun 2020
94.32
1 May 2020
94.24
1 Apr 2020
93.4
1 Mar 2020
92.87
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of E. coli bacteraemia resistant to co-amoxiclav. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Resistance data for rolling monthly average percent of E. coli bacteraemia resistant to co-amoxiclav. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
% resistant
1 Jan 2025
43.05
1 Dec 2024
42.85
1 Nov 2024
42.78
1 Oct 2024
42.77
1 Sep 2024
42.87
1 Aug 2024
42.52
1 Jul 2024
42.4
1 Jun 2024
41.65
1 May 2024
41.39
1 Apr 2024
40.91
1 Mar 2024
41.01
1 Feb 2024
41.92
1 Jan 2024
43.06
1 Dec 2023
43.91
1 Nov 2023
43.17
1 Oct 2023
42.28
1 Sep 2023
41.64
1 Aug 2023
42.2
1 Jul 2023
42.17
1 Jun 2023
42.87
1 May 2023
42.99
1 Apr 2023
43.8
1 Mar 2023
44.41
1 Feb 2023
44.39
1 Jan 2023
43.57
1 Dec 2022
42.94
1 Nov 2022
42.1
1 Oct 2022
42.14
1 Sep 2022
41.57
1 Aug 2022
41.03
1 Jul 2022
40.84
1 Jun 2022
40.91
1 May 2022
41.44
1 Apr 2022
41.65
1 Mar 2022
41.55
1 Feb 2022
41.93
1 Jan 2022
42.69
1 Dec 2021
43.17
1 Nov 2021
42.6
1 Oct 2021
41.91
1 Sep 2021
41.4
1 Aug 2021
40.85
1 Jul 2021
39.62
1 Jun 2021
39.14
1 May 2021
40.17
1 Apr 2021
41.48
1 Mar 2021
42.33
1 Feb 2021
42.55
1 Jan 2021
42.49
1 Dec 2020
42.73
1 Nov 2020
42.79
1 Oct 2020
42.9
1 Sep 2020
42.35
1 Aug 2020
42.17
1 Jul 2020
42.58
1 Jun 2020
43.65
1 May 2020
44.85
1 Apr 2020
46.32
1 Mar 2020
46.08
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average number of E. coli bacteraemia tested for resistance to gentamicin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average number of E. coli bacteraemia tested for resistance to gentamicin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
Number tested
1 Jan 2025
2,985.33
1 Dec 2024
3,098.67
1 Nov 2024
3,155.67
1 Oct 2024
3,259
1 Sep 2024
3,252
1 Aug 2024
3,250.33
1 Jul 2024
3,155
1 Jun 2024
3,064.33
1 May 2024
2,998.33
1 Apr 2024
2,893
1 Mar 2024
2,873
1 Feb 2024
2,830.33
1 Jan 2024
2,830
1 Dec 2023
2,856.67
1 Nov 2023
2,940
1 Oct 2023
3,075.33
1 Sep 2023
3,136.33
1 Aug 2023
3,121.33
1 Jul 2023
3,050
1 Jun 2023
2,909.33
1 May 2023
2,825.67
1 Apr 2023
2,678
1 Mar 2023
2,631.67
1 Feb 2023
2,525.33
1 Jan 2023
2,614.67
1 Dec 2022
2,666.67
1 Nov 2022
2,867.67
1 Oct 2022
2,939.67
1 Sep 2022
2,993
1 Aug 2022
2,856.33
1 Jul 2022
2,735
1 Jun 2022
2,648
1 May 2022
2,647.67
1 Apr 2022
2,577.67
1 Mar 2022
2,547.67
1 Feb 2022
2,505.67
1 Jan 2022
2,572.33
1 Dec 2021
2,594.67
1 Nov 2021
2,697.67
1 Oct 2021
2,793.67
1 Sep 2021
2,900
1 Aug 2021
2,901.33
1 Jul 2021
2,878
1 Jun 2021
2,789.33
1 May 2021
2,761.33
1 Apr 2021
2,579.33
1 Mar 2021
2,470.33
1 Feb 2021
2,385.33
1 Jan 2021
2,427.33
1 Dec 2020
2,474
1 Nov 2020
2,542
1 Oct 2020
2,688
1 Sep 2020
2,760
1 Aug 2020
2,700.67
1 Jul 2020
2,559.67
1 Jun 2020
2,344.33
1 May 2020
2,352
1 Apr 2020
2,470.67
1 Mar 2020
2,794.33
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of E. coli bacteraemia tested for resistance to gentamicin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average percent of E. coli bacteraemia tested for resistance to gentamicin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
% tested
1 Jan 2025
91.17
1 Dec 2024
91.9
1 Nov 2024
92.31
1 Oct 2024
92.59
1 Sep 2024
92.2
1 Aug 2024
92.3
1 Jul 2024
92.2
1 Jun 2024
92.21
1 May 2024
92.08
1 Apr 2024
92.25
1 Mar 2024
92.41
1 Feb 2024
92.36
1 Jan 2024
92.18
1 Dec 2023
92.16
1 Nov 2023
92.42
1 Oct 2023
93.13
1 Sep 2023
93.19
1 Aug 2023
93.22
1 Jul 2023
93.36
1 Jun 2023
93.63
1 May 2023
93.92
1 Apr 2023
93.64
1 Mar 2023
94.2
1 Feb 2023
94.11
1 Jan 2023
94.5
1 Dec 2022
94.74
1 Nov 2022
94.65
1 Oct 2022
94.78
1 Sep 2022
95.11
1 Aug 2022
95.87
1 Jul 2022
96.27
1 Jun 2022
96.26
1 May 2022
96.5
1 Apr 2022
96.92
1 Mar 2022
96.88
1 Feb 2022
96.83
1 Jan 2022
96.37
1 Dec 2021
96.4
1 Nov 2021
96.39
1 Oct 2021
96.51
1 Sep 2021
96.73
1 Aug 2021
96.8
1 Jul 2021
97.03
1 Jun 2021
97.01
1 May 2021
97.12
1 Apr 2021
97.17
1 Mar 2021
97.24
1 Feb 2021
97.19
1 Jan 2021
97.24
1 Dec 2020
97.32
1 Nov 2020
97.28
1 Oct 2020
97.22
1 Sep 2020
97.15
1 Aug 2020
97.33
1 Jul 2020
97.56
1 Jun 2020
97.87
1 May 2020
97.39
1 Apr 2020
97.05
1 Mar 2020
96.68
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of E. coli bacteraemia resistant to gentamicin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Resistance data for rolling monthly average percent of E. coli bacteraemia resistant to gentamicin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
% resistant
1 Jan 2025
12.29
1 Dec 2024
12.45
1 Nov 2024
11.92
1 Oct 2024
11.62
1 Sep 2024
12.22
1 Aug 2024
12.71
1 Jul 2024
12.95
1 Jun 2024
12.52
1 May 2024
12.75
1 Apr 2024
12.86
1 Mar 2024
12.52
1 Feb 2024
12.13
1 Jan 2024
11.81
1 Dec 2023
11.83
1 Nov 2023
11.83
1 Oct 2023
11.72
1 Sep 2023
11.77
1 Aug 2023
11.98
1 Jul 2023
11.75
1 Jun 2023
11.8
1 May 2023
11.34
1 Apr 2023
11.07
1 Mar 2023
10.44
1 Feb 2023
10.53
1 Jan 2023
10.82
1 Dec 2022
11.22
1 Nov 2022
10.46
1 Oct 2022
10.64
1 Sep 2022
10.45
1 Aug 2022
10.79
1 Jul 2022
10.52
1 Jun 2022
10.51
1 May 2022
10.37
1 Apr 2022
10.68
1 Mar 2022
10.35
1 Feb 2022
10.56
1 Jan 2022
10.38
1 Dec 2021
10.42
1 Nov 2021
9.98
1 Oct 2021
9.64
1 Sep 2021
9.37
1 Aug 2021
9.29
1 Jul 2021
9.2
1 Jun 2021
9.46
1 May 2021
9.74
1 Apr 2021
9.83
1 Mar 2021
9.43
1 Feb 2021
9.43
1 Jan 2021
9.24
1 Dec 2020
10.08
1 Nov 2020
10.48
1 Oct 2020
10.63
1 Sep 2020
10.31
1 Aug 2020
9.94
1 Jul 2020
10.29
1 Jun 2020
10.52
1 May 2020
10.52
1 Apr 2020
10.83
1 Mar 2020
10.95
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average number of E. coli bacteraemia tested for resistance to piperacillin with tazobactam. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average number of E. coli bacteraemia tested for resistance to piperacillin with tazobactam. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
Number tested
1 Jan 2025
2,968.67
1 Dec 2024
3,067.67
1 Nov 2024
3,072.33
1 Oct 2024
3,107.67
1 Sep 2024
3,064
1 Aug 2024
3,042.67
1 Jul 2024
2,972.67
1 Jun 2024
2,891.33
1 May 2024
2,830.33
1 Apr 2024
2,720.33
1 Mar 2024
2,686.33
1 Feb 2024
2,659.33
1 Jan 2024
2,650.33
1 Dec 2023
2,698.33
1 Nov 2023
2,785.67
1 Oct 2023
2,910.33
1 Sep 2023
2,958
1 Aug 2023
2,943.67
1 Jul 2023
2,877
1 Jun 2023
2,748.33
1 May 2023
2,657.33
1 Apr 2023
2,531.33
1 Mar 2023
2,474
1 Feb 2023
2,382
1 Jan 2023
2,456.33
1 Dec 2022
2,478.33
1 Nov 2022
2,662
1 Oct 2022
2,729.33
1 Sep 2022
2,809
1 Aug 2022
2,695.67
1 Jul 2022
2,583.67
1 Jun 2022
2,504.33
1 May 2022
2,490
1 Apr 2022
2,414.33
1 Mar 2022
2,398
1 Feb 2022
2,364.67
1 Jan 2022
2,441.67
1 Dec 2021
2,456.67
1 Nov 2021
2,541.33
1 Oct 2021
2,626.67
1 Sep 2021
2,714
1 Aug 2021
2,723.33
1 Jul 2021
2,699.67
1 Jun 2021
2,630
1 May 2021
2,601
1 Apr 2021
2,435.67
1 Mar 2021
2,329.33
1 Feb 2021
2,243
1 Jan 2021
2,276.67
1 Dec 2020
2,316
1 Nov 2020
2,394.67
1 Oct 2020
2,538.33
1 Sep 2020
2,606.67
1 Aug 2020
2,539.67
1 Jul 2020
2,407.67
1 Jun 2020
2,206.33
1 May 2020
2,218
1 Apr 2020
2,321.33
1 Mar 2020
2,626
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of E. coli bacteraemia tested for resistance to piperacillin with tazobactam. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average percent of E. coli bacteraemia tested for resistance to piperacillin with tazobactam. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
% tested
1 Jan 2025
90.65
1 Dec 2024
90.98
1 Nov 2024
89.88
1 Oct 2024
88.27
1 Sep 2024
86.87
1 Aug 2024
86.4
1 Jul 2024
86.85
1 Jun 2024
87
1 May 2024
86.92
1 Apr 2024
86.73
1 Mar 2024
86.39
1 Feb 2024
86.78
1 Jan 2024
86.32
1 Dec 2023
87.06
1 Nov 2023
87.55
1 Oct 2023
88.13
1 Sep 2023
87.9
1 Aug 2023
87.9
1 Jul 2023
88.06
1 Jun 2023
88.45
1 May 2023
88.33
1 Apr 2023
88.5
1 Mar 2023
88.58
1 Feb 2023
88.78
1 Jan 2023
88.79
1 Dec 2022
88.06
1 Nov 2022
87.88
1 Oct 2022
88
1 Sep 2022
89.26
1 Aug 2022
90.47
1 Jul 2022
90.92
1 Jun 2022
91.02
1 May 2022
90.78
1 Apr 2022
90.79
1 Mar 2022
91.21
1 Feb 2022
91.38
1 Jan 2022
91.46
1 Dec 2021
91.27
1 Nov 2021
90.81
1 Oct 2021
90.74
1 Sep 2021
90.53
1 Aug 2021
90.86
1 Jul 2021
91
1 Jun 2021
91.48
1 May 2021
91.49
1 Apr 2021
91.75
1 Mar 2021
91.69
1 Feb 2021
91.4
1 Jan 2021
91.19
1 Dec 2020
91.11
1 Nov 2020
91.62
1 Oct 2020
91.79
1 Sep 2020
91.73
1 Aug 2020
91.53
1 Jul 2020
91.77
1 Jun 2020
92.11
1 May 2020
91.84
1 Apr 2020
91.2
1 Mar 2020
90.87
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of E. coli bacteraemia resistant to piperacillin with tazobactam. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Resistance data for rolling monthly average percent of E. coli bacteraemia resistant to piperacillin with tazobactam. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
% resistant
1 Jan 2025
12.95
1 Dec 2024
12.72
1 Nov 2024
11.47
1 Oct 2024
11.46
1 Sep 2024
11.47
1 Aug 2024
12.02
1 Jul 2024
12.38
1 Jun 2024
12.72
1 May 2024
12.44
1 Apr 2024
12.46
1 Mar 2024
12.11
1 Feb 2024
12.68
1 Jan 2024
12.6
1 Dec 2023
12.76
1 Nov 2023
12.76
1 Oct 2023
12.59
1 Sep 2023
12.11
1 Aug 2023
12.21
1 Jul 2023
12.15
1 Jun 2023
12.84
1 May 2023
12.43
1 Apr 2023
12.51
1 Mar 2023
11.75
1 Feb 2023
11.39
1 Jan 2023
10.76
1 Dec 2022
10.49
1 Nov 2022
10.76
1 Oct 2022
11
1 Sep 2022
11.26
1 Aug 2022
10.92
1 Jul 2022
10.73
1 Jun 2022
10.54
1 May 2022
10.67
1 Apr 2022
10.74
1 Mar 2022
10.16
1 Feb 2022
9.81
1 Jan 2022
10.08
1 Dec 2021
10.96
1 Nov 2021
11.08
1 Oct 2021
10.8
1 Sep 2021
10.34
1 Aug 2021
10.01
1 Jul 2021
9.64
1 Jun 2021
9.68
1 May 2021
9.46
1 Apr 2021
9.59
1 Mar 2021
9.42
1 Feb 2021
10.09
1 Jan 2021
9.78
1 Dec 2020
9.53
1 Nov 2020
9.2
1 Oct 2020
9.24
1 Sep 2020
9.21
1 Aug 2020
8.83
1 Jul 2020
8.5
1 Jun 2020
8.29
1 May 2020
8.96
1 Apr 2020
9.94
1 Mar 2020
10.09
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average number of E. coli bacteraemia tested for resistance to third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average number of E. coli bacteraemia tested for resistance to third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
Number tested
1 Jan 2025
3,125
1 Dec 2024
3,242.67
1 Nov 2024
3,305
1 Oct 2024
3,408
1 Sep 2024
3,414.33
1 Aug 2024
3,410.67
1 Jul 2024
3,319.67
1 Jun 2024
3,217.67
1 May 2024
3,151
1 Apr 2024
3,029
1 Mar 2024
2,998
1 Feb 2024
2,957
1 Jan 2024
2,968
1 Dec 2023
3,002
1 Nov 2023
3,088.67
1 Oct 2023
3,204.33
1 Sep 2023
3,264
1 Aug 2023
3,240.33
1 Jul 2023
3,159.67
1 Jun 2023
3,013.33
1 May 2023
2,921
1 Apr 2023
2,784.67
1 Mar 2023
2,711
1 Feb 2023
2,601.67
1 Jan 2023
2,673.67
1 Dec 2022
2,720.33
1 Nov 2022
2,925.33
1 Oct 2022
2,995
1 Sep 2022
3,037.33
1 Aug 2022
2,880
1 Jul 2022
2,754.67
1 Jun 2022
2,685
1 May 2022
2,684.33
1 Apr 2022
2,603.33
1 Mar 2022
2,568.67
1 Feb 2022
2,526
1 Jan 2022
2,611
1 Dec 2021
2,630
1 Nov 2021
2,726.67
1 Oct 2021
2,813.33
1 Sep 2021
2,916
1 Aug 2021
2,920
1 Jul 2021
2,890.67
1 Jun 2021
2,804.33
1 May 2021
2,772
1 Apr 2021
2,586.67
1 Mar 2021
2,479.33
1 Feb 2021
2,399.67
1 Jan 2021
2,443.33
1 Dec 2020
2,480.67
1 Nov 2020
2,551.67
1 Oct 2020
2,704.33
1 Sep 2020
2,774.67
1 Aug 2020
2,697.33
1 Jul 2020
2,538.67
1 Jun 2020
2,316.33
1 May 2020
2,332.33
1 Apr 2020
2,458
1 Mar 2020
2,787
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of E. coli bacteraemia tested for resistance to third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Testing data for rolling monthly average percent of E. coli bacteraemia tested for resistance to third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
% tested
1 Jan 2025
95.45
1 Dec 2024
96.17
1 Nov 2024
96.69
1 Oct 2024
96.82
1 Sep 2024
96.8
1 Aug 2024
96.85
1 Jul 2024
96.99
1 Jun 2024
96.81
1 May 2024
96.78
1 Apr 2024
96.59
1 Mar 2024
96.43
1 Feb 2024
96.51
1 Jan 2024
96.68
1 Dec 2023
96.87
1 Nov 2023
97.08
1 Oct 2023
97.03
1 Sep 2023
97
1 Aug 2023
96.77
1 Jul 2023
96.69
1 Jun 2023
96.97
1 May 2023
97.11
1 Apr 2023
97.34
1 Mar 2023
97.06
1 Feb 2023
96.94
1 Jan 2023
96.64
1 Dec 2022
96.66
1 Nov 2022
96.57
1 Oct 2022
96.58
1 Sep 2022
96.5
1 Aug 2022
96.68
1 Jul 2022
96.94
1 Jun 2022
97.6
1 May 2022
97.85
1 Apr 2022
97.89
1 Mar 2022
97.68
1 Feb 2022
97.64
1 Jan 2022
97.83
1 Dec 2021
97.73
1 Nov 2021
97.43
1 Oct 2021
97.2
1 Sep 2021
97.26
1 Aug 2021
97.43
1 Jul 2021
97.44
1 Jun 2021
97.53
1 May 2021
97.5
1 Apr 2021
97.44
1 Mar 2021
97.6
1 Feb 2021
97.76
1 Jan 2021
97.88
1 Dec 2020
97.56
1 Nov 2020
97.63
1 Oct 2020
97.79
1 Sep 2020
97.64
1 Aug 2020
97.22
1 Jul 2020
96.76
1 Jun 2020
96.7
1 May 2020
96.56
1 Apr 2020
96.58
1 Mar 2020
96.44
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
Rolling monthly average percent of E. coli bacteraemia resistant to third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Resistance data for rolling monthly average percent of E. coli bacteraemia resistant to third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".
Up to and including 1 January 2025
Month
% resistant
1 Jan 2025
17.31
1 Dec 2024
17.67
1 Nov 2024
17.25
1 Oct 2024
17.06
1 Sep 2024
17.16
1 Aug 2024
16.99
1 Jul 2024
17.34
1 Jun 2024
16.94
1 May 2024
17.08
1 Apr 2024
16.73
1 Mar 2024
16.08
1 Feb 2024
16
1 Jan 2024
15.77
1 Dec 2023
16.3
1 Nov 2023
16.04
1 Oct 2023
15.8
1 Sep 2023
15.85
1 Aug 2023
15.82
1 Jul 2023
15.94
1 Jun 2023
16.05
1 May 2023
16.09
1 Apr 2023
16.05
1 Mar 2023
15.25
1 Feb 2023
15.48
1 Jan 2023
15.26
1 Dec 2022
15.39
1 Nov 2022
14.79
1 Oct 2022
14.75
1 Sep 2022
14.83
1 Aug 2022
14.57
1 Jul 2022
14.51
1 Jun 2022
14.15
1 May 2022
14.02
1 Apr 2022
13.67
1 Mar 2022
13.56
1 Feb 2022
13.22
1 Jan 2022
13.65
1 Dec 2021
13.33
1 Nov 2021
13.46
1 Oct 2021
13.27
1 Sep 2021
13.36
1 Aug 2021
13.54
1 Jul 2021
13.33
1 Jun 2021
13.44
1 May 2021
13.37
1 Apr 2021
13.54
1 Mar 2021
13.98
1 Feb 2021
14.18
1 Jan 2021
13.79
1 Dec 2020
13.72
1 Nov 2020
13.18
1 Oct 2020
13.41
1 Sep 2020
12.83
1 Aug 2020
13.05
1 Jul 2020
13.04
1 Jun 2020
13.48
1 May 2020
14.46
1 Apr 2020
15.23
1 Mar 2020
15.73
Download
About
Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change.
Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months.
Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.
The ESPAUR report includes national data on antimicrobial prescribing and resistance, antimicrobial stewardship implementation, and awareness activities.